NDC 17856-0672-01 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0672
- Requested NDC
- 17856-0672-01
- Package NDCs from labels
- 17856-0672-1, 17856-0672-2, 17856-0672-3, 17856-0672-4, 17856-0672-01
- Manufacturer
- Atlantic Biologics Corp.
- Effective date
- 2025-10-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - Atlantic Biologics Corp. | Atlantic Biologics Corp. | 2025-10-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0672-1 | Ondansetron | 60 in 1 CASE | SOLUTION | 60 | 1 | |
| 17856-0672-1 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-2 | Ondansetron | 120 in 1 CASE | SOLUTION | 120 | 1 | |
| 17856-0672-2 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-3 | Ondansetron | 120 in 1 CASE | SOLUTION | 120 | 1 | |
| 17856-0672-3 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-4 | Ondansetron | 72 in 1 CASE | SOLUTION | 72 | 1 | |
| 17856-0672-4 | Ondansetron | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0672-1 | ML - Milliliter | 17856-0672 | f5b97fd9-6050-46e6-b0da-693821d3938a | 1 | 2026-03-17 |
| 17856-0672-2 | ML - Milliliter | 17856-0672 | 787cc894-2cc2-4952-981c-f67609a087e3 | 1 | 2026-03-17 |
| 17856-0672-3 | ML - Milliliter | 17856-0672 | 53831650-5a50-4e31-9590-1c0ac60dc7ec | 1 | 2026-03-17 |
| 17856-0672-4 | ML - Milliliter | 17856-0672 | 68c3eadb-fcbb-40cc-80d0-0ddc4021b83a | 1 | 2026-02-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DCH Hemorrhoidal | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0050701f-4393-3f01-e063-6394a90a4e0e | 2024-12-19 | Warnings | PDC6A3C0OX |
| Revivol Hemorrhoid and Fissure | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0140cf68-b6a0-4378-e063-6394a90afee8 | 2024-12-19 | Warnings | PDC6A3C0OX |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Quality Care Products, LLC | 2e0b1b09-9e68-4728-82d5-1f86510a0f2a | 2024-12-19 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Quality Care Products LLC | 54e8981e-6880-4d4f-bc46-600c2af59698 | 2024-12-18 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Quality Care Products LLC | 89091629-d15e-4e95-aed8-8bc983c78302 | 2024-12-18 | Warnings, Adverse reactions | NMH84OZK2B |
| Equaline Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | United Natural Foods, Inc. dba UNFI | 739237a5-cc62-8ad6-e053-2991aa0a91f8 | 2024-12-17 | Warnings | XF417D3PSL |
| RECTICARE | LIDOCAINE AND GLYCERIN | Ferndale Laboratories, Inc. | 2b94136a-4975-2925-e054-00144ff88e88 | 2024-12-17 | Warnings | PDC6A3C0OX |
| Alka-Seltzer Heartburn and Pain | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Bayer HealthCare LLC. | 2928e140-c868-5bf5-e063-6394a90ab024 | 2024-12-13 | Warnings | XF417D3PSL |
| Rite Aid Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Rite Aid | b4797380-9cef-d640-e053-2a95a90a0665 | 2024-12-11 | Warnings | XF417D3PSL |
| Top Value Effervescent Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICAROBONATE | Tower Laboratories Ltd | 44babed8-cf38-1c12-e054-00144ff8d46c | 2024-12-11 | Warnings, Adverse reactions | XF417D3PSL |
| Best Choice Effervescent Antacid Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Valu Merchandisers Company | b5e2300a-b77b-53cc-e053-2a95a90a7a6e | 2024-12-11 | Warnings | XF417D3PSL |
| Burts Bees Rapid Rescue Cold Sore Treatment | CAMPHOR, GLYCERIN | Burts Bees | 9f89735d-205f-4d3e-a1e1-ecc96284fe98 | 2024-12-03 | Warnings | PDC6A3C0OX |
| CVS Health Extra Strength Antacid and Pain Reliever | ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE | CVS Pharmacy | afe9e755-18ba-305f-e053-2995a90aa8d0 | 2024-11-14 | Warnings | XF417D3PSL |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Pharmaceutical Associates, Inc. | 63201a61-6ac5-41ae-8b2d-ff0d3a8ddfd5 | 2024-11-13 | Adverse reactions | XF417D3PSL |
| Walgreens Effervescent Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Walgreens | 667418fc-a3ab-cbc7-e053-2a91aa0a2023 | 2024-11-13 | Warnings | XF417D3PSL |
| Up and Up Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Target Corporation | a72eef45-b985-638a-e053-2995a90aa20a | 2024-11-13 | Warnings | XF417D3PSL |
| Signature Care Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Safeway, Inc | 6e120024-475a-73af-e053-2a91aa0a42a6 | 2024-11-13 | Warnings, Adverse reactions | XF417D3PSL |
| Kroger Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Kroger Company | 6d858b0e-a3c8-2686-e053-2991aa0acc06 | 2024-11-13 | Warnings | XF417D3PSL |
| TopCare Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Topco Associates LLC | 639f9d57-f26a-708a-e053-2a91aa0a6962 | 2024-11-13 | Warnings, Adverse reactions | XF417D3PSL |
| Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | H. E. Butt Grocery Company | 6418cde9-607b-4ca1-e053-2991aa0a9170 | 2024-11-13 | Warnings | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.